We are delighted to unveil the latest innovation in our aortic portfolio –
The first off-the-shelf MDR CE mark approved single branch endoprosthesis.
This device is designed to address the endovascular repair of all lesions of the
descending thoracic aorta (including isolated lesions, such as aneurysm and
traumatic transection, and Type B dissections) while maintaining flow into the
left subclavian artery.
What makes it stand out is its off-the-shelf configuration allowing for a single
procedure zone 2 intervention, resulting in a more efficient and streamlined
procedure.
- Iclo
- 26 - 27 March 2024
- More information here
